Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period

Goto A, Harada S, Sasano H, Sandhu Y, Tanabe Y, Abe S, Ueda S, Takeshige T, Matsuno K, Nagaoka T, Ito J, Atsuta R, Takahashi K, Harada N

Journal of Asthma and Allergy 2024, 17:1173-1186

Published Date: 14 November 2024